Based on this review, we may hypothesize that the difference in COVID-19 susceptibility and severity between two patients with similar age and comorbid profiles, which we have experienced clinically during the pandemic, can be related to the difference in ACE2 expression in their different organs. This evidence concerns the gene ACE2 and COVID-19.